These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Evolution of HIV resistance mutations in the Valme referral center]. Nogales MC; Castro C; Martín-Mazuelos E Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915 [No Abstract] [Full Text] [Related]
12. [HIV genotypic mutation selectively induced by the protease inhibitor nelfinavir at codon 30. Case series and consequences for antiretroviral management]. Manfredi R; Calza L Infez Med; 2002 Sep; 10(3):151-6. PubMed ID: 12704265 [TBL] [Abstract][Full Text] [Related]
13. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. Hogg RS; Bangsberg DR; Lima VD; Alexander C; Bonner S; Yip B; Wood E; Dong WW; Montaner JS; Harrigan PR PLoS Med; 2006 Sep; 3(9):e356. PubMed ID: 16984218 [TBL] [Abstract][Full Text] [Related]
14. Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. Romano L; Venturi G; Giomi S; Pippi L; Valensin PE; Zazzi M J Med Virol; 2002 Feb; 66(2):143-50. PubMed ID: 11782921 [TBL] [Abstract][Full Text] [Related]
15. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019 [TBL] [Abstract][Full Text] [Related]
16. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic. Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489 [TBL] [Abstract][Full Text] [Related]
17. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain. Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V; AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258 [TBL] [Abstract][Full Text] [Related]
18. Different evidence of key amprenavir resistance mutations on the efficacy of darunavir. Di Biagio A; Rosso R; Bruzzone B; Cenderello G; Dentone C; Mularoni A; Ferrea G; Icardi G; Viscoli C AIDS; 2008 Jan; 22(3):437-8. PubMed ID: 18195574 [No Abstract] [Full Text] [Related]
19. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. Shafer RW; Rhee SY; Pillay D; Miller V; Sandstrom P; Schapiro JM; Kuritzkes DR; Bennett D AIDS; 2007 Jan; 21(2):215-23. PubMed ID: 17197813 [TBL] [Abstract][Full Text] [Related]
20. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. SPREAD programme AIDS; 2008 Mar; 22(5):625-35. PubMed ID: 18317004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]